News

Mylan is not assuming any of Bioniche Pharma’s outstanding debt or acquiring the company’s cash as part of the transaction. Mylan expects to finance this transaction using a

GSK stated that the FDA, in making its final decision, is expected to consider the recommendation of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety

Eisai Inc has received exclusive rights to market and distribute Lorcaserin in the US from Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals. Eisai said that

Axxess Pharma said that Fortex drug is indicated for the relief of pain and inflammation of musculoskeletal conditions such as arthritis and muscle soreness. As per a license

Mr Peacock is expected to take up the responsibility for Amgen’s finance and investor relations operations. Most recently, Mr Peacock has served as the CFO and administration officer

Amira’s newly granted claims cover new inhibitors of the FLAP protein. The patent also discloses uses of FLAP inhibitors for the treatment of inflammatory diseases such as asthma,

Keryx said that currently, Perifosine is in Phase 3 clinical development for refractory advanced colorectal cancer and multiple myeloma, both of these Phase 3 programs being conducted under

Palex had recently launched Detect-Ready MRSA assay into the Spanish market. MDI claimed that with the Detect-Ready MRSA assay, healthcare providers would benefit with enhanced accuracy, speed, flexibility

Earlier, Aestus has identified several products to treat certain psychiatric disorders. Now in partnership with Eisai, Aestus is expected to use those products for potential subsequent development in